These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6602652)
21. The in vitro response of turkey lymphocytes to steroid hormones. Redig PT; Dunnette JL; Mauro L; Sivanandan V; Markham F Avian Dis; 1985; 29(2):373-83. PubMed ID: 4026731 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of steroid hormone sensitivity of human breast cancer cells in culture (MCF-7) by a colony formation method]. Nomura Y; Matsui K; Tashiro H; Hamada Y; Saeki K Gan To Kagaku Ryoho; 1983 May; 10(5):1335-41. PubMed ID: 6870300 [TBL] [Abstract][Full Text] [Related]
23. Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids. Galili U; Leizerowitz R; Moreb J; Gamliel H; Gurfel D; Polliack A Cancer Res; 1982 Apr; 42(4):1433-40. PubMed ID: 7060016 [TBL] [Abstract][Full Text] [Related]
25. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855 [TBL] [Abstract][Full Text] [Related]
27. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals. Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237 [TBL] [Abstract][Full Text] [Related]
28. Ribonucleotide content of mononuclear cells from normal subjects and patients with chronic lymphocytic leukemia: increased nicotinamide adenine dinucleotide concentration in chronic lymphocytic leukemia lymphocytes. Liebes LF; Krigel RL; Conklyn M; Nevrla DR; Silber R Cancer Res; 1983 Nov; 43(11):5608-17. PubMed ID: 6604577 [TBL] [Abstract][Full Text] [Related]
29. [Effect of some steroid hormones on the growth of Trichomonas vaginalis]. Martinotti MG; Savoia D G Batteriol Virol Immunol; 1985; 78(1-6):52-9. PubMed ID: 3879810 [TBL] [Abstract][Full Text] [Related]
30. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells. De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639 [TBL] [Abstract][Full Text] [Related]
31. Anticancer drugs: effect on the cloning of Raji lymphoma cells in soft agar. Wu PC; Ozols RF; Hatanaka M; Boone CW J Natl Cancer Inst; 1982 Jan; 68(1):115-21. PubMed ID: 6948121 [TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man. Buick RN; Messner HA; Till JE; McCulloch EA J Natl Cancer Inst; 1979 Feb; 62(2):249-55. PubMed ID: 310906 [TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
34. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL). Pu Q; Bianchi P; Bezwoda WR Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327 [TBL] [Abstract][Full Text] [Related]
35. A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states. Fox RI; Hueniken M; Fong S; Behar S; Royston I; Singhal SK; Thompson L J Immunol; 1983 Aug; 131(2):762-7. PubMed ID: 6602845 [TBL] [Abstract][Full Text] [Related]
36. Selenite is a potent cytotoxic agent for human primary AML cells. Olm E; Jönsson-Videsäter K; Ribera-Cortada I; Fernandes AP; Eriksson LC; Lehmann S; Rundlöf AK; Paul C; Björnstedt M Cancer Lett; 2009 Sep; 282(1):116-23. PubMed ID: 19345479 [TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
38. Lack of selective killing by steroids in normal and malignant cells. Weichselbaum RR; Little JB; Nove J; Hellman S; Piro AJ J Cell Physiol; 1980 Jun; 103(3):429-33. PubMed ID: 7400225 [TBL] [Abstract][Full Text] [Related]